Is ADMA Biologics, Inc. overvalued?

ADMA Biologics, Inc. (ADMA) — key valuation metrics and fundamentals.

No verdict

Price

$9.39

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.18B

Dividend yield

0.0%

Return on equity

39.6%

Sector

Healthcare

Fair value compares ADMA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks